Linum narbonense: A new valuable tool for biotechnological production of a potent anticancer lignan Justicidine B
Iliana Ionkova1, Pavlina Sasheva1, Todor Ionkov2, Georgi Momekov1
1 Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria
2 Department of Automation, Faculty of Automatics, Technical University of Sofia, 1000 Sofia, Blv. Kl. Ohridski 8, Bulgaria
|Date of Submission||25-Jan-2012|
|Date of Decision||13-Feb-2012|
|Date of Web Publication||05-Mar-2013|
BG 1000 Sofia, Medical University of Sofia Faculty of Pharmacy, 2 Dunav Str
Source of Support: Ministry of Education and Science, Sofia, Bulgaria (D002-128/2008 and DTK 02-1/2009)., Conflict of Interest: None
| Abstract|| |
Background: Arylnaphthalene lignan Justicidin B is a lead compound in the management of bone cancer and osteoclastogenesis . The compound is the main cytotoxic principle of rare medicinal plant Linum narbonense L. (Linaceae). However, there have been no reports on the bioreactor production of justicidin B. Objective: to develop cost-effective biotechnology for production of this anticancer metabolite. Materials and Methods: The genetic transformation in hairy roots induced by Agrobacterium rhizogenes strain ATCC 15834, was proven by PCR analysis. The control of bioreactor was synthesized by gradient method. The optimal values of the controlling parameters were estimated with presence of technological limitation. The general structure of control system was based on "Hardware in the Loop" (HIL). Results: Hairy roots produced five-fold higher yields of justicidin B (7.78mg/g DW) compared to callus. A rapidly growing root line was selected for cultivation in 2-L stirred tank bioreactor. After optimization, maximum biomass of 22.5 g.l -1 dry wt was harvested from the bioreactor culture vessel (recording about 8 times increase over initial inoculum), with 1.42 % ± 0.12 Justicidine B, greater than contents from flasks were obtained. The extracts were tested in a panel of human tumor cell lines, using the MTT-dye reduction assay, exert inhibitory effects against malignant cells. Conclusion: Our findings are the first work on large cultivation of L. narbonense hairy roots and bioreactor production of plant anticancer agent Justicidin B. To extend the research to human clinical studies, we have found a reliable biotechnological supply of plant material, produced this target compound.
Keywords: Cytotoxic lignans, justicidin B, Linum narbonense, stirred tank bioreactor, hairy roots
|How to cite this article:|
Ionkova I, Sasheva P, Ionkov T, Momekov G. Linum narbonense: A new valuable tool for biotechnological production of a potent anticancer lignan Justicidine B. Phcog Mag 2013;9:39-44
|How to cite this URL:|
Ionkova I, Sasheva P, Ionkov T, Momekov G. Linum narbonense: A new valuable tool for biotechnological production of a potent anticancer lignan Justicidine B. Phcog Mag [serial online] 2013 [cited 2022 Jan 22];9:39-44. Available from: http://www.phcog.com/text.asp?2013/9/33/39/108138
| Introduction|| |
Lignans are a large group of natural products, which show diverse biological effects. Lignans may serve as lead compounds for the development of new therapeutic agents with cytotoxic, antiangiogenic, antiviral, antileishmanial, antifungal, hypolipidemic, antiasthmatic and antiviral activity. 
Justicidin B is an arylnaphthalene lignan from Linum spp.  and previously known from Justicia spp. (Acanthaceae) and Haplophyllum spp. (Rutaceae). Since the structure of justicidin B is closely related to podophyllotoxin, it was hypothesized that justicidin B may have similar cytotoxic effects as those reported for podophyllotoxin. Justicidin B was established to be the cytotoxic principle of Justicia pectoralis and demonstrated to have strong antiviral activity.  The fungicidal and antiprotozoal effects of Phyllanthus piscatorum were attributed to justicidin B.  It was also reported that justicidin B significantly inhibits platelet aggregation.  The potent bone resorption inhibitor justicidin B was used as lead compound for new antirheumatic drugs.  Several tumor types including sarcomas and breast, prostate, and lung carcinomas grow in or preferentially metastasize to the skeleton where they proliferate, and induce significant bone remodeling, bone destruction, and cancer pain.  Thus, justicidin B may have significant clinical utility as a lead compound in the management of bone cancer and osteoclastogenesis , due to its cytotoxic and bone resorption inhibitory properties. Since there is a growing interest in justicidin B due to its various pharmacological effects, the sustainable biotechnological supply of this valuable lignan would be a feasible alternative. The plant-specific secondary products were long considered as a major limitation for an extensive use of plant-made pharmaceuticals in human therapy. To extend the research to human clinical studies, we needed to find a reliable supply of plant material, produced target compounds. In our laboratory, we focus on the production of some important anticancer agents in plant cell cultures.
Our preliminary experiments exhibited that justicidin B is the main cytotoxic principle in the methanolic extract of Linum narbonense L. (Linaceae).  "Hairy root," an infectious plant disease caused by the soil bacteria Agrobacterium rhizogenes natural genetic engineer, is at the core of a promising new technique that could one day lead to "biofactories" that produce medicines derived from rare plants in huge quantities at a low cost.  Therefore, we decided to establish hairy roots from this species in hope of produce justicidin B in high yields.
The objective of this study is to develop cost-effective laboratory bio-technology for production of this anticancert metabolite. So we are paying attention not only to fundamental scientific tasks - to determine the lignan content in the different cell cultures from Linum narbonense L. (Linaceae) and to examine the cytotoxic activity of the extracts, but also to those related to some of the technological problems associated with bioreactor production of justicidin B and their optimization.
| Materials and Methods|| |
The seeds of L. narbonense were provided by the botanical garden of Zurich (Switzerland).
Cell plant cultures
Seeds of L. narbonense were germinated under sterile conditions on hormone free MS-medium in the dark.  Sterile grown seedlings were used for initiation of callus cultures. Cell suspension cultures were derived from the callus cultures by transferring 5g callus cells to 50 ml medium in a 300 ml Erlenmeyer flask. Standard medium for callus and suspension cultures was MS-medium containing kinetin 2 mg/l, 2,4-dichlorophenoxyacetic acid 0.1 mg/l and indole-acetic acid 0.2 mg/l. Callus cultures were transferred every three weeks into 100 ml fresh medium. Calli were incubated under permanent light. The suspension cultures were sub cultivated every 12 days by transferring 5 g wet cells with a perforated spoon into 50 ml fresh medium. Suspension cultures were grown in dark at 120 rev./min.
Hairy root induction and cultivation in bioreactor
Hairy roots were induced by direct incubation of segments from sterile grown plants with Agrobacterium rhizogenes strain ATCC 15834 cultured in YMB medium  in the presence of 20 μM acetosyringone for 2 days in the dark, which increased susceptibility toward infection. The fast growing hairy roots were further maintained under permanent dark on a rotary shaker.
A rapidly growing root line of L. narbonense, was selected for cultivation in stirred tank bioreactor "BIOSTAT B Plus" for 40 days. After four weeks of cultivation in Erlenmeyer flasks, the hairy roots were scaled up to a 2-L bioreactor. Upon this subculture, the harvested roots were inoculated in bioreactor after being cut to of about 1.0 cm length.
Fermentations were carried out in 2 l jacketed glass vessel applying cultivation. Equipment of the vessel includes: sensors for temperature, pH, dissolved oxygen concentration, foam, and speed of stirrer drive system; four integrated peristaltic pumps and one external pump for flow control and feeding. Bioreactor conditions: temperature - 26 o C, batch mode of cultivation, dissolved oxygen saturation (DO at 60%), marine-type impeller design with low-shear stress, speed 140 rpm. This impeller provides mixing and creates a higher oxygen mass transfer rate (Kla).
Control system has the following functions: display of all process values via schematic P&ID algorithms, digital calibration of sensors and pump dosing counters indication of sensor parameters, recalibration function of pH-probe, control loops for temperature, stirrer speed, pH, pO2, foam, level, substrate, pO2 with two stage cascade control, set point profile for substrate pumps.
Data acquisition system includes the following functions: data collection, data base maintenance, visualization of the process variables by several plotting functions. This software allows starting or finished process batches, exporting database in appropriate data formants and sample data configuration.
Extraction and isolation of lignans
Lignans were extracted from powdered lyophilised cells (200mg) with MeOH (2ml). The mixture was further homogenized in an ultrasonic bath (2 × 30s) with intermediate cooling on ice. Distilled water (6ml) was added and the pH was adjusted to 5.0 by adding a few drops of 5% phosphoric acid. After adding b-glucosidase (1mg), the sample was incubated at 35°C for 1 h in a water bath. MeOH (12ml) was added and the mixture was incubated for another 10 min at 70°C in an ultrasonic bath. After centrifugation for 7 min at 4500 rev./min the volume of supernatant was determined. One ml of the supernatant was taken and centrifuged at 13000 rev./min for 5 min at 25°C. This final solution was used for HPLC analysis.
The HPLC determination was performed on a Thermo Quest (Egelsbach, Germany) equipped with a Spectra SYSTEM UV6000LP detector. The separation column was a GROM-SIL 120 ODS-5 ST (250 × 4mm, particle size 5μm) supplied with a precolumn (20 × 4mm, particle size 5μm); the gradient system was water with 0.01% phosphoric acid (85%) (A) and acetonitrile (B) as follows: 0 to 17 min from 40% to 67% B, from 17 to 18 min back to 40% B. The flow rate was 0.8 ml/min between 0 and 17 min, 1 ml/min between 17 and 24 min and again 0.8 ml/ min after 24 min. The retention time of justicidin B is about 16.0 min, detector wavelength 290nm.
DNA isolation was conducted from the dry plant material of intake plant, calli, and hairy roots according to a protocol for rapid isolation from dry and fresh samples. The isolation of DNA of A. rhizogenes ATCC 15834 was performed following the instructions of Qiaprep spin miniprep kit. The integration of rol A and rol C genes from A. rhizogenes into the plant genome, which is the genetic evidence for hairy root transformation, was proven by PCR, as described earlier. 
Cell lines and culture conditions
The antiproliferative action of the extracts was tested against panel malignant cell lines (the chronic myeloid leukemia - derived cell lines K-562 and LAMA-84, the Hodgkin lymphoma-derived HD-MY-Z and the human urinary bladder carcinoma-derived EJ cells) with etoposide as a positive control. The leukemic cells were supplied from the German Collection of Microorganisms and Cell Cultures (DSMZ GmbH, Braunschweig, Germany), whereas the human urinary bladder carcinoma-derived cell line EJ was obtained from the American Type Culture collection (Rockville, MD, USA). The cells were maintained as suspension type culture (leukemias), semiadherent culture (HD-MY-Z) or monolayer culture (EJ) in a controlled environment: RPMI-1640 medium, supplemented with 10% fetal calf serum and 2.5 mg/ ml L-glutamine in an incubator with 5% CO 2 humidified atmosphere at 37ξΡ. The cells were kept in log-phase by trypsinization and consequent supplementation with fresh medium, 2-3 times per week.
Drug solutions, treatment and cytotoxicity determination
Stock solutions of the extracts were freshly prepared in ethanol water and were consequently diluted with RPMI-1640 medium to yield the final concentrations. Etoposide (as a commercially sterile available dosage form) was dissolved in water for injections and accordingly diluted in RPMI-1640. Cells were seeded into 96-well plates (100 μl/well at a density of 1 × 10 5 cells/ml) and exposed to the tested extracts or etoposide for 72h. Cell survival was determined with the MTT dye-reduction assay as described by Mosmann  with some modifications.  Briefly, after the incubation with the test-compound, MTT-solution (10mg/ml in PBS) was added (10 μl/well). Plates were further incubated for 4 h at 37 o C and the formazan crystals formed were dissolved by adding 100 μl/well of 5% formic acid in 2-propanol. Absorption was measured on an ELISA spectrophotometer (Uniscan; Titertek, Helsinki, Finland) at 540nm. For each concentration at least eight wells were used. As a blank solution 100 μl RPMI 1640 medium with 10 μl MTT stock and 100 μl 5% formic acid in 2-propanol was used. Each MTT test was run in quadruplicate.
The MTT data were normalized as percentage of the untreated control (set as 100%) and fitted to sigmoidal concentration-response curves and the corresponding IC 50 values were calculated using non-linear regression analysis (GraphPad Prizm software package). Statistical processing exploited Student's t-test with P ≤ 0.05 set as significance level.
| Results and Discussion|| |
While the most intensive search for biotechnological production of lignans is focused on podophyllotoxin and related aryltetralin lignans, suitable for the semisynthetic production of etoposide and teniposide  the intensive investigation of other lignan compounds has revealed some attractive lead compounds with potent cytotoxic and other biological activities. Important examples are the arylnaphtalene lignans justicidin A-E, originally identified in Justicia procumbens.
Justicidin B [Figure 1], has been shown to be a potent cytotoxic and proapoptotic agent against the breast cancer derived cell lines MDA-MB-231 and MCF-7. This is a potential lead compound for the development of lignan-based antineoplastic agents.  The EI-MS of the justicidin B  showed an ion at m/z 364 and mass fragmentation, which is consistent with the data for an arylnaphthalene lignin.  Further NMR experiments were performed in order to distinguish between justicidin B and isojusticidin B as these two isomers have slightly different MS fragmentation pattern. A closer look at the 1H NMR spectrum showed that the proton signals at δ 7.12ppm and δ 7.05ppm appeared as singlets, which is indicative only for 4,5-dimethoxy substitution. Therefore the resonance signals at δ 7.12 ppm and δ 7.05 ppm were assigned to H-6 and H-3 respectively, due to the shielding effect of the piperonyl group from the pendant ring. Thus the compound can be unambiguously identified as justicidin B.
|Figure 1: Structure of Justicidine B, isolated from hairy roots of L. narbonense.|
Click here to view
Seeds of L. narbonense were germinated and shoot cultures were developed from them. From single seedlings callus and subsequently suspension cultures were initiated. Calli cultures were developed as previously described.  A rapidly growing root line of L. narbonense was selected for cultivation in stirred tank bioreactor, because they have been considered to be sensitive in mechanically agitation. The genetically modified cultures demonstrated typical hairy roots phenotype: intensive branching, hormone autotrophy and lack of geotropism. The most vigorous growth was observed when the bacterial growth stopped and there was no further necessity of antibiotic. We performed analysis of the transferred DNA (T-DNA) from Agrobacterium rhizogenes to L. narbonense transformed cells in order to confirm the hairy roots transformation using the cell line genomic DNA as template in the polymerase chain reaction (PCR) assays. The T-DNA has left (T L ) and right (T R ) borders. The T L region in plasmid T-DNA of agropine-type strain A. rhizogenes 15834 contains 18 open reading frames including several loci called rol (root loci).  The products encoded by rol A and rol C genes were found to have a synergistic effect on root induction and induce increased sensitivity to auxin. PCR analysis showed that hairy roots from L. narbonense contain rol C and rol A genes corresponding to the positive controls obtained by DNA from A. rhizogenes ATCC 15834. Untransformed callus served as a negative control. The second gene system necessary for T-DNA transfer consists of virulence (vir) genes encoded by a region outside the T-DNA. The protein coded by vir D 2 provides an endonuclease that initiates the transfer process by nicking T-DNA at a specific site. Vir D 2 was not detected in the hairy roots, thus showing that T-DNA is incorporated in the plant genome and it is not a residual bacterial contamination.
The amounts of justicidin B were determined as aglycone after enzymatic hydrolysis with β-glucosidase. The presence of justicidin B was verified using HPLC. The content of justicidin B in the L. narbonense intact roots is about 0.5mg/g DW, in callus cultures is 1.57mg/g dwt. Suspensions of L. narbonense contain much smaller amounts of justicidin B, 0.09mg/g dwt [Table 1]. Hairy roots produced 5-fold higher justicidin B (7.78mg/g DW) compared to callus. To our knowledge, no reports on induction of hairy roots from L. narbonense and bioreactor cultivation have been published until now.
Bioreactor strategy for transformed roots of L. narbonense
The aim of this study was to establish a bioreactor culture of Linum narbonense (Linaceae) as a renewable source of potent anticancer arylnaphtalene lignan justicidin B. A rapidly growing selected root line of L. narbonense was grown in 2-L stirred tank bioreactor for period of forty days. In order to reach effective production we have to combine two factors - both lignan content and biomass growth. Cell growth dynamics and production of justicidine B of Linum narbonense cells cultivated under different conditions in shake-flasks and in a 2-L bioreactor were compared. It was recognized that a transformed roots showed a growth-associated product formation and have low oxygen demand, unlike suspension cultures where change in oxygen level can significantly affect growth and productivity. Rheological characteristics of heterogeneous system should also be taken into consideration during mass scale culturing of hairy roots. Concerning the establishment of a bioreactor system it was of importance to find an appropriate aeration level for maintaining the dissolved oxygen sufficiently high without creating a shear-intensive environment. Several control schemes for bioprocess have been investigated up to this date, a good compendium of them can be found in.  Our investigation addresses the study of a control approach for regulation of the cultivation process in bioreactor of L. narbonense hairy roots. In this study the control of bioreactor was synthesized by gradient method. The optimal values of the controlling parameters were estimated with presence of technological limitation. We have investigated the controllability and observable ability of bioreactor plant system: "BIOSTAT B Plus" and L. narbonense hairy roots. Controlling system achieved accuracy in dynamic regimes 8% errors, in static regimes - 2.5% errors. The general structure of control system is based of "Hardware in the Loop" (HIL) and is presented in [Figure 2]. Input-Output interface is based on RT-DAC4/PCI - INTECO (Intelligent Technology for Control). Control algorithm included several integrators blocks. Several simulations were carried out to test this scheme using an experimentally identified process model.
|Figure 2: The general structure of control system is based of „Hardware in the Loop" (HIL)|
Click here to view
After forty days of sterile run cultivation of hairy root culture in bioreactor, 22.5g.l -1 dry wt of root biomass was harvested from the bioreactor culture vessel, recording about 8 times increase over initial inoculum (3.0g), with 1.42% ± 0.12 Justicidine B, greater than contents from a 300ml flasks. Our findings are the first work on large cultivation of L. narbonense hairy roots and bioreactor production of plant anticancer agent Justicidin B, employing bioreactors for high biomass production to meet the industrial requirement, led to the successful commercialization of plant cell bioprocesses.
The cytotoxic potential of the L. narbonense hairy root extracts was investigated after 72 h continuous exposure, by means of the MTT-dye reduction assay for cell viability in a panel of human cancer cell lines, representative for some common human malignancies. Up to now the L. narbonense hairy root extracts were not tested for the cytotoxic potential on the human tumor cell lines, used in this study. The data were fitted to sigmoidal dose-response curves and the corresponding IC 50 values were calculated using non-linear regression (curve fit).
The tested extracts inhibited the proliferation of the malignant cells (the chronic myeloid leukemia-derived cell lines K-562 and LAMA-84, the Hodgkin lymphoma-derived HD-MY-Z and the human urinary bladder carcinoma-derived EJ cells) in a concentration-dependent manner, which allowed the construction of dose-response curves (not shown) and the calculation of the corresponding IC50 (mg/ml) values (concentrations causing 50% decrease of cell viability), summarized in [Table 2]. The extracts showed a moderate cytotoxicity to all tested cell lines with IC50 in the range from 0.029 to 0.812mg/ml. The cell lines displayed differential sensitivity towards tested extracts whereby LAMA-84 cells were found to be most susceptible, K-562 and HD-MY-Z were less responsive and the urinary-bladder carcinoma EJ proved to be the most resistant cell line among the panel investigated. The cytotoxic effects may be directly linked to the content of justicidin B.
|Table 2: Cytotoxicity of the tested L. narbonense hairy roots extracts in a panel of human tumor cell lines after 72h exposure (MTT- assay)|
Click here to view
| Conclusion|| |
Some of the most effective cancer treatments to date are natural products or compounds derived from plant products. Recently, the interest of international pharmaceutical industries has been directed more and more to plant based anticancer compounds. Isolation of anticancer pharmaceuticals from plants is difficult due to their extremely low concentrations. The industry currently lacks sufficient methods for producing all of the desired plant-derived pharmaceutical molecules. Some substances can only be isolated from extremely rare plants. Plant cell cultures are an attractive alternative source to whole plant for the production of high-value secondary metabolites.  Our results indicate that hairy root culture is a valuable alternative approach for obtaining of potential anticancer agent Justicidine B from L. narbonense.
Bioreactor studies represent the final step leading to commercial production of economically important phytochemicals from plant cell cultures. Although a number of economically important compounds have been produced by plant cell and tissue culture techniques, production of compounds on an industrial scale is still restricted. 
In conclusion, these results prove that the selected high productive hairy root clone of L. narbonense, inducing by Agrobacterium rhizogenes ATCC 15834 can be a valuable alternative approach for the production of arylnaphthalene lignan Justicidin B. This bioreactor system is a feasible alternative for the production of the cytotoxic metabolites of L. narbonense on a large scale. Using Input-Output interface, based on RT-DAC4/PCI - INTECO (Intelligent Technology for Control), including several integrators blocks, a relatively high lignan production can be achieved. Justicidin B has been shown to be a potent cytotoxic and proapoptotic agent against the human chronic myeloid leukemia and breast cancer derived cell lines.  To extend the research to human clinical studies, we have found a reliable biotechnological supply of plant material, produced this target compounds.
| Acknowledgements|| |
Financial support from Ministry of Education and Science, Sofia, Bulgaria (D002-128/2008 and DTK 02-1/2009) is acknowledged.
| References|| |
|1.||Ayers DC, Loike JD. Lignans: Biological and clinical properties. Cambridge: Cambridge University Press; 1990. |
|2.||Mohagheghzadeh A, Schmidt TJ, Alfermann AW. Arylnaphthalene lignans from in vitro cultures of Linum austriacum. J Nat Prod 2002;65:69-71. |
|3.||Gleye HJ, Moulis C, Mensah LJ, Roussakis C, Gratas C. Justicidin B: A cytotoxic principle from Justicia pectoralis. J Nat Prod 1988;51:599-600. |
|4.||MacRae WD, Hudson JB, Towers GH, The antiviral action of lignans. Planta Med 1989;55:531-5. |
|5.||Gertsch J, Tobler RT, Brun R, Sticher O, Heilmann J. Antifungal, antiprotozoal, cytotoxic and piscicidal properties of Justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum. Planta Med 2003;69:420-4. |
|6.||Chen CC, Hsin WC, Ko FN, Huang YL, Ou JC, Teng CM. Antiplatelet effect and selective binding to Cyclooxygenase (COX) by molecular docking analysis of flavonoids and lignans. J Nat Prod 1996;59:1149. |
|7.||Baba A, Kawamura N, Makino H, Ohta Y, Taketomi S, Sohda T. Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect. J Med Chem 1996;39:5176-82. |
|8.||Sabino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, et al. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002;62:7343-9. |
|9.||Vasilev N, Ionkova I. Cytotoxic activity of extracts from Linum cell cultures. Fitoterapia 2005;76:50-3. |
|10.||Georgiev MI, Pavlov AI, Bley T. Hairy root type plant in vitro systems as sources of bioactive substances. Appl Microbiol Biotechnol 2007;74:1175-85. |
|11.||Murashige T, Scoog F. A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol Plant 1962;15:473-97. |
|12.||Vasilev N, Elfahmi, Bos R, Kayser O, Momekov G, Konstantinov S, et al. Production of justicidin B: A cytotoxic arylnaphthalene lignan from genetically transformed root cultures of Linum leonii. J Nat Prod 2006;69:1014-7. |
|13.||Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. |
|14.||Konstantinov S, Eibl MH, Berger MR. BCR-ABL influences the antileukemic efficacy of alkylphosphocholines. Br J Haematol 1999;107:365-74. |
|15.||Schmidt TJ, Hemmati S, Klaes M, Konuklugil B, Mohagheghzadeh A, Ionkova I, et al. Alfermann, Lignans in Linum species - Chemodiversity in the light of systematics and phylogeny. Phytochemistry 2010;71:1714-28. |
|16.||Momekov G, Konstantinov S, Dineva I, Ionkova I. Justicidin B: A potent arylnaphtalene lignan on human breast cancer derived cell lines. Neoplasma 2011;58:320-5. |
|17.||Lübert A, Simutis R. Measurement and Control. In: Ratledge C and Kristiansen B. Basic biotechnology. UK: Cambridge University Press; 2001. |
|18.||Ionkova I. Anticancer lignans - from discovery to biotechnology. Mini Rev Med Chem 2011;11:1-14. |
|19.||Ionkova I. Pharmaceutically significant biologically active compounds from sources with optimized phytochemical potential. Thesis of Dr. of Science, Sofia, 2008. |
[Figure 1], [Figure 2]
[Table 1], [Table 2]
|This article has been cited by|
||Lignans from linseed (Linum usitatissimum L.) and its allied species: Retrospect, introspect and prospect
| ||Himanshu Chhillar, Priyanka Chopra, Mohd Ashraf Ashfaq |
| ||Critical Reviews in Food Science and Nutrition. 2021; 61(16): 2719 |
|[Pubmed] | [DOI]|
||New Insight into Justicidin B Pathway and Production in Linum austriacum
| ||Iride Mascheretti, Michela Alfieri, Massimiliano Lauria, Franca Locatelli, Roberto Consonni, Erica Cusano, Roméo A. Dougué Kentsop, Marina Laura, Gianluca Ottolina, Franco Faoro, Monica Mattana |
| ||International Journal of Molecular Sciences. 2021; 22(5): 2507 |
|[Pubmed] | [DOI]|
||Biotechnological approaches to the production of plant-derived promising anticancer agents: An update and overview
| ||Li Changxing, Saddia Galani, Faiz-ul Hassan, Zubia Rashid, Muhammad Naveed, Daidong Fang, Asma Ashraf, Wang Qi, Afsheen Arif, Muhammad Saeed, Arif Ali Chishti, Li Jianhua |
| ||Biomedicine & Pharmacotherapy. 2020; 132: 110918 |
|[Pubmed] | [DOI]|
||Justicidin B: A Promising Bioactive Lignan
| ||Shiva Hemmati,Hassan Seradj |
| ||Molecules. 2016; 21(7): 820 |
|[Pubmed] | [DOI]|
||Lignan accumulation in callus and Agrobacterium rhizogenes-mediated hairy root cultures of flax (Linum usitatissimum)
| ||Ahmed M. M. Gabr,Hoda B. Mabrok,Kadry Z. Ghanem,Michael Blaut,Iryna Smetanska |
| ||Plant Cell, Tissue and Organ Culture (PCTOC). 2016; |
|[Pubmed] | [DOI]|
||Cytotoxic effect of the biotechnologically-derived justicidin B on human lymphoma cells
| ||Y. Ilieva,I. Zhelezova,T. Atanasova,M. M. Zaharieva,P. Sasheva,I. Ionkova,S. Konstantinov |
| ||Biotechnology Letters. 2014; 36(11): 2177 |
|[Pubmed] | [DOI]|